{"nct_id":"NCT04223791","title":"Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)","status":"COMPLETED","status_verified_date":"2025-03","start_date":"2020-02-18","start_date_type":"ACTUAL","primary_completion_date":"2021-08-26","primary_completion_date_type":"ACTUAL","completion_date":"2025-02-27","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}